Articles From: Data From Phase 2b Clinical Trial of Clazakizumab, an Anti-IL-6 Monoclonal Antibody for the Treatment of Active Psoriatic Arthritis, to be Presented at the American College of Rheumatology Annual Meeting to Datawatch and ParStream Bring Blazingly Fast Visual Analytics to the Internet of Things


DANVERS, Mass., Sept.
Sign-up for Data From RECOVER RIGHT Impella RP Trial to be Announced at TCT 2014 investment picks
2014/10/31
DATA Group Ltd.
Sign-up for DATA Group Ltd. - Third Quarter 2014 Earnings Results Conference Call investment picks
Data Group Ltd.
Sign-up for Data Group Ltd. announces third quarter results for 2014 investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1152104&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O Corporation to Announce Third Quarter 2014 Financial Results on October 30, 2014 investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155302&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O Reports Third Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160100&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O to Present at LD Micro Conference on December 3rd investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148682&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O's New PSV3000 Wins Global Technology's Award for Programming investment picks
Front-runner in Managed and Cloud Services for Oracle Technologies and Applications Marks Five-Year Anniversary of Specialized Application Engineering Team and Completes Major Upgrade for Haemonetics Corporation BEDFORD, Mass.
Sign-up for Data Intensity Fortifies Track Record of Success in Oracle EBS R12 Implementations and Upgrades investment picks
Survey of CIOs and IT Decision Makers Highlights Storage and Data Management as a Critical Factor to Operational Success; Points to Software and Active Archive as Growth Opportunities SAN JOSE, Calif.
Sign-up for Data Is Currency Of New Economy, But Most Fail To Unlock Its Full Value; HGST Survey Finds 86% Of Data Center Decision-Makers Surveyed Believe That All Data Has Value investment picks
-- First-Line Use of Brincidofovir for CMV May Preserve Subsequent Therapeutic Options --
Sign-up for Data on Chimerix's Brincidofovir Suggests Favorable Resistance Profile in Adenovirus and Cytomegalovirus (CMV) investment picks
http://media.marketwire.com/attachments/201406/75933_logo1.jpg http://media.marketwire.com/attachments/201310/67907_gsk_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1152248&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA --
Sign-up for Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function Compared to Tiotropium investment picks
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced a retrospective data analysis from the CHAMPION clinical trial showing significant a reduction in 30-day hospital readmission rates for patients age 65 and older.
Sign-up for Data Shows the CardioMEMS HF System Significantly Reduced 30-Day Hospital Readmission Rates investment picks
OPKO Health, Inc. (NYSE: OPK), today announced that the abstract “Top Line Results of Once-Weekly, CTP-Modified Human Growth Hormone (MOD-4023): Phase 2 Dose Finding Study in Children with Growth Hormone Deficiency (GHD)” has been selected for late breaking oral presentation at the 53rd Annual Meeting of the European Society of Paediatric Endocrinology (ESPE) on September 20, 2014 in Dublin, Ireland.
Sign-up for Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be Presented as a Late Breaking Presentation at the European Society of Paediatric Endocrinology Conference investment picks
2014/10/9
API Integration to Benefit DataCandy Partners MONTREAL , Oct.
Sign-up for DataCandy Partners With Blackhawk Network (Canada) To Power Digital Gift Cards investment picks
Datalink (Nasdaq: DTLK), a leading provider of data center infrastructure and services, announced today that it will issue a news release on Tuesday October 21, 2014, at approximately 3:00 p.m. Central Time to announce third quarter operating results for 2014.
Sign-up for Datalink 2014 Third Quarter Operating Results Conference Call investment picks
Datalink (Nasdaq:DTLK), a leading provider of data center infrastructure and services, today announced an agreement to acquire privately held Bear Data Solutions, Inc. (Bear). The acquisition of San Francisco-based Bear will quadruple Datalink’s West Coast revenue base to more than $200 million, expand its Cisco expertise into strategically important new areas, and add more than 1,000 new midmarket and enterprise customers to whom Datalink can market its comprehensive portfolio of data center offerings.
Sign-up for Datalink Acquires IT Solutions Provider Bear Data Solutions, Inc. investment picks
Datalink (NASDAQ:DTLK), a leading provider of data center infrastructure and services, today announced that Patricia A.
Sign-up for Datalink Corporation Announces New Human Resources Leader investment picks
Datalink (Nasdaq: DTLK), a leading provider of data center infrastructure and services, today reported results for its third quarter and nine months that ended September 30, 2014.
Sign-up for Datalink Reports 2014 Third Quarter and Nine Month Operating Results investment picks
2014/8/27
On August 27, 2014, Dataram Corporation (the “Company”) announced that it has determined to postpone the 2014 Annual Meeting of the Stockholders of the Company (the “Annual Meeting”), originally scheduled to be held at 2:00 p.m., Eastern Daylight Time, on Thursday, September 18, 2014.
Sign-up for Dataram Announces Postponement of Its Annual Meeting of Shareholders investment picks
2014/11/18
On November 17, 2014, Dataram Corporation (the “Company”; NASDAQ:DRAM) and certain institutional investors, including Isaac Capital Group, as lead investor, closed a securities purchase agreement (the “Purchase Agreement”), pursuant to which the Company agreed to sell up to an aggregate of 1,300,000 shares of its Series A Preferred Stock (the “Series A Stock”), together with warrants to purchase shares of common stock, to such investors at a price of $5.00 per share (the “Preferred Stock Transaction”). The sale of the Series A Stock will take place in multiple tranches.
Sign-up for Dataram Announces Sale of up to $6.5 Million of Series A Preferred Stock, Election of New Directors and Other Results of Shareholders’ Meeting investment picks
2014/10/21
On October 20, 2014, Dataram Corporation (the “Company”) and certain investors entered into a securities purchase agreement (the “Purchase Agreement”), pursuant to which the Company agreed to sell up to an aggregate of 1,300,000 shares of its Series A Preferred Stock (the “Series A Stock”) together with warrants to purchase shares of common stock, to such investors at a price of $5.00 per share (the “Preferred Stock Transaction”). The sale of the Series A Stock will take place in multiple tranches.
Sign-up for Dataram Announces Sale of up to $6.5 Million Series A Preferred Stock and Set New Shareholders Meeting Date investment picks
2014/9/15
On September 12, 2014, Dataram Corporation (the “Company”) announced that on September 11, 2014, the Company was notified by the Listing Qualifications Staff of The NASDAQ Stock Market LLC that, based upon the Company’s non-compliance with the minimum $2,500,000 stockholders’ equity requirement for continued listing on The NASDAQ Capital Market, the Company’s securities are subject to delisting unless the Company timely requests a hearing before a NASDAQ Listing Qualifications Panel (the “Panel”). The Company intends to timely request a hearing before the Panel, at which hearing the Company will present its plan to evidence and sustain compliance with all applicable requirements for continued listing on NASDAQ.
Sign-up for Dataram Receives NASDAQ Listing Notification; Intends to Request Hearing investment picks
Dataram Corporation (NASDAQ:DRAM) today reported its financial results for its fiscal first quarter ended July 31, 2014.
Sign-up for Dataram Reports Fiscal 2015 First Quarter Financial Results investment picks
2014/10/20
CHELMSFORD, Mass.
Sign-up for Datawatch and ParStream Bring Blazingly Fast Visual Analytics to the Internet of Things investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Data From Phase 2b Clinical Trial of Clazakizumab, an Anti-IL-6 Monoclonal Antibody for the Treatment of Active Psoriatic Arthritis, to be Presented at the American College of Rheumatology Annual Meeting to Datawatch and ParStream Bring Blazingly Fast Visual Analytics to the Internet of Things
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent